Skip to main content
. Author manuscript; available in PMC: 2020 Jan 24.
Published in final edited form as: Subst Abus. 2019 Jan 24;40(3):292–301. doi: 10.1080/08897077.2018.1545726

Table 3.

Among those identified with an alcohol or drug (AOD) use disorder in an outpatient or emergency department setting (N=69,965), characteristics associated with initiation of AOD treatment

Characteristic associated with AOD treatment initiation Population (N=69,965) N (%) or median (IQR) Unadjusted RR for initiation (95% CI) Adjusted RR for initiation (95% CI)
Race/ethnicity
White 41571 (59.4) [Ref] [Ref]
Asian 2502 (3.6) 0.80 (0.77–0.83) 0.80 (0.78–0.82)
African American 6653 (9.5) 0.80 (0.74–0.87) 0.80 (0.75–0.86)
Hispanic 14043 (20.1) 0.83 (0.80–0.87) 0.84 (0.80–0.87)
Other/Unknown 5196 (7.4) 0.92 (0.75–1.12) 0.93 (0.76–1.13)

Age 46.4 (17.7) 1.01 (1.00–1.01) --

Sex
Male 37600 (60.9) [Ref] [Ref]
Female 27390 (39.1) 0.92 (0.83–1.03) 0.92 (0.82–1.03)

Charlson/Deyo comorbidity index
0 46708 (66.8) [Ref] [Ref]
1 11557 (16.5) 1.08 (1.02–1.13) 0.99 (0.96–1.03)
2+ 11700 (16.7) 0.91 (0.86–0.96) 0.80 (0.74–0.86)

Diagnoses in the prior year

 Alcohol abuse 7824 (11.2) 1.86 (1.67–2.08) 1.57 (1.32–1.86)

 Tobacco dependence 14102 (20.2) 1.37 (1.23–1.54) 1.30 (1.17–1.43)

 Pregnancy/childbirth 1073 (1.5) 0.97 (0.70–1.35) --

 Injury/poisoning 22027 (31.5) 1.19 (1.07–1.32) --

 Cirrhosis 3790 (5.4) 1.36 (1.30–1.41) 1.25 (1.12–1.35)

 Hepatitis C 1695 (2.4) 1.17 (1.09–1.26) --

 Pancreatic disease 1083 (1.5) 1.59 (1.43–1.77) 1.34 (1.15–1.56)

Abbreviations. IQR=interquartile range; RR = risk ratio; CI = confidence interval; AOD=alcohol or other drugs; -- indicates variables not included in adjusted analyses because they either were not significant in bivariate analyses (p-value ≥ 0.25) or forward selection modeling (p-value ≥ 0.25)